Athenahealth, Inc.
ATHN
ATHN was delisted on the 11th of February, 2019.
214 hedge funds and large institutions have $6.69B invested in Athenahealth, Inc. in 2015 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 68 increasing their positions, 76 reducing their positions, and 21 closing their positions.
43% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 21
18% more capital invested
Capital invested by funds: $5.69B → $6.69B (+$1B)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
4% more funds holding
Funds holding: 206 → 214 (+8)
6% less call options, than puts
Call options by funds: $113M | Put options by funds: $120M
11% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 76
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$76M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$50.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$31.2M |
| 4 |
Select Equity Group
New York
|
+$21M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$18.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$26.7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$23.1M |
| 3 |
VAM
Visium Asset Management
New York
|
-$19.8M |
| 4 |
HAM
HHR Asset Management
Berkeley Heights,
New Jersey
|
-$18M |
| 5 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$12.9M |
ATHN Hedge Fund Activity: Q3 2015 in Review
214 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Athenahealth, Inc. (ATHN) for Q3 2015, worth a combined $6.69B — up 18% from $5.69B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new ATHN positions and 21 closed out — a net gain of 9 holders — while 68 added to existing stakes and 76 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $76M. The largest seller was Morgan Stanley, cutting an estimated $26.7M.
- 214 institutional investors held Athenahealth, Inc. (ATHN) as of Q3 2015, up from 206 in Q2 2015.
- Funds reported $6.69B of Athenahealth, Inc. stock for Q3 2015, up 18% quarter-over-quarter.
- 30 funds opened new Athenahealth, Inc. positions in Q3 2015 and 21 closed out, a net change of +9 holders.
- The largest Athenahealth, Inc. buyer in Q3 2015 was T. Rowe Price Associates, an estimated $76M added.
- The largest Athenahealth, Inc. seller in Q3 2015 was Morgan Stanley, an estimated $26.7M sold.
Based on aggregated 13F filings for Q3 2015.